Tango Therapeutics Alternatives & Competitors
12 companies similar to Tango Therapeutics — Targeting tumor suppressor loss to unmask vulnerabilities for the next generatio...
Companies similar to Tango Therapeutics
TransCode Therapeutics, Inc.
Delivering a cancer-free future
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
TME Pharma
Developing novel therapies for treatment of the most aggressive cancers by acting on the t...
Tarveda Therapeutics
To discover, develop and commercialize a new class of potent and selective precision oncol...
Rival Readout
Competing with Tango Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Mural Oncology
Leveraging our protein engineering platform to improve cytokine-based immunotherapies for...
Normunity
Biotech company creating a new class of precision immuno-oncology medicines that enable no...
Pear Bio
Patient-centered cancer precision medicine
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Inspirna, Inc.
Converting cancer to a manageable, chronic condition
Tyra Biosciences
TYRA is focused on developing next-generation precision medicines that target large opport...
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision me...
Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations
Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors
Clinical-stage, Precision Medicine, Cancer Treatment, Tumor Suppressor Targeting, Synthetic Lethality, CRISPR-based Discovery, DNA Sequencing, Immuno-oncology, Oncogenic Drivers, Immune Evasion, Functional Genomics, Drug Discovery, Targeted Therapies, Novel Drug Targets
B2B, B2B2C
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tango Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tango Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.